
Functional Cure for Diabetes? First Patient Shows Insulin Response Without Immunosuppression – Sana Biotechnology
In a groundbreaking clinical milestone that may transform the future of type 1 diabetes (T1D) management, Sana Biotechnology has announced compelling six-month results from its first-in-human trial using hypoimmune-engineered islet cells. For the first …